Trial Profile
Two versus three doses of Menjugate in infants from Germany.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2011
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine group C conjugate (Primary) ; Hib-DTaP-hepatitis B-poliovirus vaccine; Meningococcal vaccine groups A and C polysaccharide
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Meningococcal group C infections; Pertussis; Poliomyelitis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Chiron Behring
- 27 Jun 2011 New source for the extension trial identified and integrated (European Clinical Trials Database record EudraCT2004-005150-31).